Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-15-001861
Filing Date
2015-03-19
Accepted
2015-03-19 17:05:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 rule424b5prospectus.htm 424B5 125558
2 GRAPHIC image2.jpg GRAPHIC 18131
  Complete submission text file 0001628280-15-001861.txt   151608
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-202494 | Film No.: 15713512
SIC: 2834 Pharmaceutical Preparations